USFDA gives approval for Lenalidomide capsules

"The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone."

159
USFDA Drug product Approval
USFDA Approval

Last Updated on December 24, 2023 by The Health Master

Aurobindo Pharma said its wholly-owned subsidiary firm Eugia Pharma Specialities has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Lenalidomide Capsules used to treat multiple myeloma.

Lenalidomide Capsules — 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 25 mg — are bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Revlimid Capsules — 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 25 mg — of Bristol-Myers Squibb Company, the firm said in a statement.

The product is expected to be launched in October 2023.

“This is the 155th ANDA (including 9 tentative approvals received) out of Eugia Pharma Speciality Group (EPSG) facilities, manufacturing both oral and sterile speciality products,” it said.

“The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone.”

Hyderabad-headquartered Aurobindo Pharma manufactures a wide range of generic pharmaceuticals, branded speciality pharmaceuticals and active pharmaceutical ingredients globally in over 150 countries.

USFDA approves Nasal spray for opioid overdose

USFDA gives final approval for Prazosin Hydrochloride capsules

USFDA gives nod for Fluorouracil Injection USP

USFDA gives approval for Vigabatrin for Oral Solution

USFDA gives approval for Rocuronium Bromide Injection

USFDA gives nod for Docetaxel Injection USP

IDMA urges IPC to revise DT for Soft Gelatin Capsules

USFDA approves Nasal spray for opioid overdose

Pharma Industry urged to report overcharging cases to NPPA

National Medical Commission aims to streamline Medical Education

USFDA flags shortage of medication used to treat breathing conditions

IPC joins dialogue between EP, JP & USP for Pharmacopoeial harmonisation

Health Minister directs FDA officers to promote generic drugs

Drug recall: 4,000 bottles of Tacrolimus Capsules recalled due to this reason

Understanding DQ, IQ, PQ, and OQ in the Pharma Industry

Duties and responsibilities of QA person in Pharma Industry

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news